Filcad P Injection


Product Info

Prescription required Yes
Marketer Cadila Pharmaceuticals Ltd
Active Ingredient Pegfilgrastim (6mg)
Storage Store in a refrigerator (2 - 8°C). Do not freeze.
Chemical ClassGranulocyte Colony-Stimulating Factor
Habit FormingNo
Therapeutic ClassANTI NEOPLASTICS
Action ClassGranulocyte-colony stimulating factor (G-CSF)
User Rating4.3
User Reviews412

FAQ

Question
What is Filcad P? How is it given?
Filcad P belongs to a class of medications called colony stimulating factors. It helps reduce the chances of infections and side effects related to chemotherapy and does not directly treat cancer. It comes as a solution (liquid) to inject subcutaneously (under the skin), 24 hours after chemotherapy. It may be injected by a doctor/nurse in a hospital or you may be shown how to use injections at home
Answer

Question
How does pegfilgrastim work?
Pegfilgrastim belongs to a class of medications called colony stimulating factors. It acts on hematopoietic cells (cells in the bone marrow that produce red blood cells, white blood cells, and platelets) to increase production of neutrophils (a type of white blood cell) in the body.
Answer
Question
What if you forget to take Filcad P?
If you miss a dose of Filcad P, please consult your doctor.
Answer

Filcad P Injection Reviews

Filcad P is used to prevent infections after chemotherapy. It is a growth factor that stimulates bone marrow to produce white blood cells. These cells protect the body against infections.

Filcad P is given as an injection by a qualified medical professional. You should continue to take as long as your doctor advises for it. The duration of treatment varies according to your need and response to treatment. You might be asked for regular tests done to check the number of blood cells in your blood and your bone density level while you are taking this medicine.

The most common side effects of this medicine include bone pain, joint pain, headache, nausea, and muscle pain. Other than this, pain or redness at the site of injection is common. But, inform your doctor if you notice a lump, swelling, or bruising that does not go away. It might not prevent you from all kinds of infection, hence inform your doctor if you notice fever, chills, shortness of breath, sore throat, and swelling around the face or neck.

Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. You must avoid driving or attention-seeking activity if you experience dizziness after taking this medicine.

How Filcad P Injection Works

Filcad P is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections. .

How to Use Filcad P Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Benefits of Filcad P Injection

  • In Prevention of Infections after chemotherapy: Filcad P increases the production of white blood cells by stimulating the immune system in our body. White blood cells are those cells that help us to fight infections. This medicine is really effective and must be used under medical supervision. Avoid being in crowds and wash your hands often to prevent any infections. Have plenty of fluids, unless otherwise advised by the doctor not to.

Uses of Filcad P Injection

  • Prevention of Infections after chemotherapy

Filcad P Injection Side Effects

Item form

Safety Tips

Alcohol  CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Filcad P. Please consult your doctor.
Driving  SAFE
Filcad P does not usually affect your ability to drive.
Kidney  SAFE IF PRESCRIBED
Filcad P is safe to use in patients with kidney disease. No dose adjustment of Filcad P is recommended.
Breast feeding  SAFE IF PRESCRIBED
Filcad P is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Pregnancy  CONSULT YOUR DOCTOR
Filcad P may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Liver  CONSULT YOUR DOCTOR
There is limited information available on the use of Filcad P in patients with liver disease. Please consult your doctor.

Quick Tips

  • Filcad P reduces the risk of infection in people treated with chemotherapy.
  • Your doctor may get regular tests done to monitor the number of blood cells in your blood, and your bone density level while you are receiving treatment with this medicine.
  • It is usually given as a daily injection into the tissue just under the skin or into the vein. 
  • Stop taking Filcad P and inform your doctor if you have a fever, shortness of breath, fast rate of breathing or trouble breathing.
  • Store it in the refrigerator, protect it from light, and don't shake it.
  • Pain or redness in the area of injection is common. Let your doctor know if you notice a lump, swelling, or bruising that doesn't go away.
  • For a more comfortable injection, leave the syringe at room temperature for 30 minutes before using it.
  • You will normally receive your first dose at least 24 hours after your chemotherapy or bone marrow transplant.
  • Use caution while driving or doing anything that requires concentration as Filcad P may cause dizziness.

References

  1. Medscape. Pegfilgrastim.
  2. Masters SB. Agents Used in Anemias; Hematopoetic Growth Factors. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 581.
  3. Pegfilgrastim. Cambridge, UK: Amgen Ltd.; 2002 [revised Sep. 2018].
  4. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1074-75.

Other Medical Preparations